Pure Global AI
NCT06074198Not yet recruiting

Sickle Cell Children's Exercise Study (SuCCESs)

Sickle Cell Children's Exercise Study Determining the Effects of a Targeted Exercise Training Program on Neuromuscular Performance, Locomotor Efficiency, and Exercise Tolerance in Children With Sickle Cell Disease.
University of Maryland, BaltimoreClinicalTrials.govbehavioral
Verified
Study focus
Disease/Condition
Sickle Cell Disease
Drug/Device/Intervention
SuCCESs
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
University of Maryland, Baltimore
Timeline & enrollment
Phase
N/A
Start date
Nov 01, 2023
End date
Oct 01, 2025
Enrollment
20 participants
Primary outcome

knee extension strength,Rate of Muscle Activation,exercise tolerance,locomotor efficiency,number of sessions attended

Summary

The Sickle Cell Children's Exercise Study (SuCCESs) will explore the feasibility and effects
 of a moderate intensity strengthening, balance, speed, and agility intervention program in
 children with sickle cell disease.

ICD-10 classifications
Sickle-cell disordersOther sickle-cell disordersSickle-cell traitSickle-cell anaemia with crisisSickle-cell anaemia without crisis
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06074198
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06074198 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Maryland, Baltimore and is currently Not yet recruiting. The study focuses on Sickle Cell Disease. Target enrollment is 20 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.